Cancer Drug Costs Under Supreme Court Scrutiny: ₹2,700 Cost, ₹27,000 MRP Raises Serious Questions
New Delhi, September 29, 2026 (SDNA) — The rising cost of cancer treatment has once again come under judicial scrutiny, with the Supreme Court raising pointed questions over the wide gap between the cost of medicines and their maximum retail prices. During Tuesday’s hearing on petitions concerning the pricing of cancer medicines, the bench of Justice Vikram Nath and Justice Sandeep Mehta was presented with an example of a medicine reportedly costing around ₹2,700 but carrying an MRP of ₹27,000. The substantial difference prompted the court to question how such pricing affects patients and who ultimately bears the financial burden. Who ultimately pays the additional cost? The court also examined the issue from the perspective of government-funded healthcare schemes. Questions were ...